Nonprofit Hospitals Under Scrutiny
Recently, Washington received a wake-up call regarding the true nature of once-revered charity hospitals. When House Ways and Means Chairman Jason Smith proposed that nonprofit hospitals clarify how their tax-exempt status benefits patient care, hospital lobbyists quickly responded with implicit threats to lawmakers involved.
The proposal was withdrawn under pressure, with the American Hospital Association (AHA) indicating that its members would fight hard against transparency measures that could disrupt their status quo.
This reaction prompts an important question: what exactly are nonprofit hospitals trying to conceal?
These tax-exempt hospitals receive over $50 billion every year in various tax benefits at federal, state, and local levels. The logic behind this support is clear. In return, these institutions are expected to provide significant community benefits, particularly charity care for low-income individuals. It seemed like a well-meaning policy aimed at aiding those in need.
However, the reality has shifted. Many large hospital systems appear to operate more like complex financial enterprises rather than true charities, while still enjoying the benefits associated with their nonprofit status.
Take consolidation, for example. Over the last decade, tax-exempt hospitals have significantly expanded into large regional systems, absorbing physician practices and outpatient facilities. This growth has given them considerable power over insurers, leading to increased premiums and out-of-pocket costs for patients. A report from the Congressional Budget Office has indicated that hospital consolidation raises prices without clear advancements in quality.
These situations are not coincidental. The current environment incentivizes size and market dominance, which provide leverage not only against insurers and pharmacy benefit managers but also against employees and patients.
The 340B drug pricing program adds to the complications. Initially designed to assist hospitals that cater to significant numbers of low-income patients, the program allows eligible hospitals to purchase drugs at steep discounts. The assumption was that hospitals would then pass these savings onto their patients.
In reality, many hospitals charge patients full price and keep the surplus. This creates a substantial revenue stream with little accountability regarding how the funds are utilized. In 2024 alone, hospitals are expected to generate tens of billions of dollars from 340B-related activities.
Additionally, concerns remain about how much charity care tax-exempt hospitals genuinely provide. Recent investigations have shown that several large systems invest far less in direct patient support than they receive in tax benefits. For instance, tax-exempt hospitals in Indiana allocated approximately 1% of their expenses to charity care in 2022.
That’s a tough discrepancy to reconcile with the initial intent behind tax exemption.
Meanwhile, many of these same hospital systems are spending heavily on ventures far from their foundational charitable missions—like advertising campaigns, branding initiatives, real estate projects, and lobbying efforts. Hospitals have recently made headlines for spending on everything from Super Bowl commercials to sports branding deals.
While none of these are inherently inappropriate, they do highlight how much the contemporary nonprofit hospital landscape has deviated from its charitable origins.
The main issue isn’t that hospitals are financially thriving; it’s that the existing framework allows them to benefit from public subsidies without clear, enforceable expectations for serving the public.
This brings us back to Smith’s proposal. The draft legislation didn’t impose price controls or extensive reforms. It merely sought greater transparency: hospitals would have to elucidate how they leverage their tax benefits and show the community support they offer.
The reaction from the hospital lobby was rapid and revealing. Industry representatives cautioned lawmakers and rallied local hospital systems to highlight the economic significance of hospitals in their districts. The message was unmistakable: reconsider any challenges.
This kind of tactics isn’t new. When even slight oversight is seen as a threat, it often indicates that the system is in dire need of examination.
None of this implies that tax-exempt hospitals don’t play a crucial role in healthcare; rather, that makes accountability even more essential. Public subsidies should be tied to measurable results, not simply assumed goodwill.
Chairman Smith and the Ways and Means Committee are headed in the right direction. A reasonable way forward would involve enhancing transparency. Policymakers could require standardized reporting on charity care and community benefits, aligning tax-exempt status more closely with actual patient support and ensuring programs like 340B function as intended. These reasonable steps could maintain flexibility while reinstating credibility.
Certainly, some hospitals are ready to embrace transparency and collaborate with Congress to refine this proposal, potentially leading to bipartisan advancement.
Given that healthcare costs continue to escalate, taxpayers deserve assurance that public funds are being utilized efficiently. If hospitals wish to enjoy tax exemption benefits, they ought to be ready to demonstrate their commitment to serving the public, rather than merely thriving within a beneficial regulatory framework.
